Federal Register of Legislation - Australian Government

Primary content

PB 74 of 2014 Determinations/Health as made
This instrument amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (No. PB 119 of 2008) to provide for pharmaceutical benefits that involve the admixture of ready-prepared ingredients; drugs that are to be used in the preparation of extemporaneously-prepared pharmaceutical benefits and that are unstable or packed sterile and unused quantities of which are unsuitable for future use; pharmaceutical benefits that are classified as dangerous drugs for the purpose of payment of a dangerous drug fee; pharmaceutical benefits the complete pack of which shall be supplied regardless of any lesser quantity ordered in the prescription; and standard formula preparations.
Administered by: Health
Made 23 Sep 2014
Registered 26 Sep 2014
Tabled HR 30 Sep 2014
Tabled Senate 30 Sep 2014
Date of repeal 02 Oct 2014
Repealed by Division 1 of Part 5A of the Legislative Instruments Act 2003

PB 74 of 2014

 

National Health Determination under paragraph 98C(1)(b) Amendment 2014
(No. 9)

_____________________________________________________________________

 

 

I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.

 

Dated 23 September 2014

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FELICITY McNEILL

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health

 

 

 

1              Name of Instrument

(1)                This Instrument is the National Health Determination under paragraph 98C(1)(b) Amendment 2014 (No. 9).

(2)                This Instrument may also be cited as PB 74 of 2014.

2              Commencement                                                        

                This instrument commences on 1 October 2014.

3              Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)

                Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).



Schedule 1            Amendments

 

[1]        Schedule 4, entry for Aclidinium

omit from the column headed “Form (strength, type, size, etc.)”:

containing aclidinium bromide 400 micrograms per dose, 60 doses

substitute:

                322 micrograms (as bromide) per dose, 60 doses

[2]        Schedule 4, after entry for Glucose Indicator—Blood in the form Test strips, 100 (Contour)

insert in the column headed “Form (strength, type, size, etc.)”:

 

Test strips, 100 (EasyMate II)

[3]        Schedule 4, entry for Oestradiol and Oestradiol with Dydrogesterone

insert as first item in the column headed “Form (strength, type, size, etc.)”:

 

Pack containing 14 tablets oestradiol 1 mg and 14 tablets oestradiol 1 mg with dydrogesterone 10 mg

[4]        Schedule 4, omit entry for Polyethylene glycol 400